Evidence map›Paper›PMID 33060297›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2020

Stimulator of interferon genes (STING) is an essential proviral host factor for human rhinovirus species A and C.

Kevin L McKnight, Karen V Swanson, Kathryn Austgen, Cindy Richards, Jonathan K Mitchell, David R McGivern, Ethan Fritch, John Johnson, Katja Remlinger, Michal Magid-Slav and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.5field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Research square · 2026
    Article
  3. Article
  4. Regulation of STING activation by phosphoinositide and cholesterol.bioRxiv : the preprint server for biology · 2025
    Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Applications of cryo-EM in drug development for STING.Current opinion in structural biology · 2024
    Review
  13. Review
  14. Review
  15. Review
  16. A determination of pan-pathogen antimicrobials?Medicine in drug discovery · 2022
    Review
  17. Article
  18. Article
  19. Article
  20. Innate immune sensing by epithelial barriers.Current opinion in immunology · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Kevin L McKnightLineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599.ORCID 0000-0002-9099-2044
Karen V SwansonDivision of Infectious Diseases, Department of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599.ORCID 0000-0003-3105-0599
Kathryn AustgenResearch & Development, GlaxoSmithKline, Collegeville, PA 19426.ORCID 0000-0002-1714-8808
Cindy RichardsResearch & Development, GlaxoSmithKline, Collegeville, PA 19426.
Jonathan K MitchellLineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599.ORCID 0000-0003-1760-8998
David R McGivernDivision of Infectious Diseases, Department of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599.
Ethan FritchDepartment of Microbiology and Immunology, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599.
John JohnsonResearch & Development, GlaxoSmithKline, Collegeville, PA 19426.
Katja RemlingerResearch & Development, GlaxoSmithKline, Collegeville, PA 19426.
Michal Magid-SlavResearch & Development, GlaxoSmithKline, Collegeville, PA 19426.ORCID 0000-0001-7272-5754
Maryna KapustinaDepartment of Cell Biology and Physiology, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599.
Shihyun YouResearch & Development, GlaxoSmithKline, Collegeville, PA 19426; shihyun.k.you@gsk.com smlemon@med.unc.edu.ORCID 0000-0003-4867-6424
Stanley M LemonLineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599; shihyun.k.you@gsk.com smlemon@med.unc.edu.ORCID 0000-0003-1450-806X
University of North Carolina at Chapel Hill · USGlaxoSmithKline (United States) · US

Funding

North Carolina Translational and Clinical Science Institute (NC TraCS) KL2KL2TR002490 · NCATS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI WEINBERGER, MORRIS · 2018 to 2022
$11.0M
Membrane Hijacking: Biogenesis and Fate of Quasi-Enveloped HepatovirusR01AI103083 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI LEMON, STANLEY M. · 2012 to 2021
$4.0M
Critical Lipid Species in the Hepatovirus LifecycleR01AI150095 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI LEMON, STANLEY M. · 2020 to 2024
$2.6M
Host Factors for RhinovirusR01AI153265 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI SWANSON, KAREN V · 2021 to 2025
$1.9M
NCATS NIH HHS KL2 TR002490NIAID NIH HHS R01 AI103083NIAID NIH HHS R01 AI150095NIAID NIH HHS R01 AI153265
6 · The paper itself

Abstract

Human rhinoviruses (RVs) are positive-strand RNA viruses that cause respiratory tract disease in children and adults. Here we show that the innate immune signaling protein STING is required for efficient replication of members of two distinct RV species, RV-A and RV-C. The host factor activity of STING was identified in a genome-wide RNA interference (RNAi) screen and confirmed in primary human small airway epithelial cells. Replication of RV-A serotypes was strictly dependent on STING, whereas RV-B serotypes were notably less dependent. Subgenomic RV-A and RV-C RNA replicons failed to amplify in the absence of STING, revealing it to be required for a step in RNA replication. STING was expressed on phosphatidylinositol 4-phosphate (PI4P)-enriched membranes and was enriched in RV-A16 compared with RV-B14 replication organelles isolated in isopycnic gradients. The host factor activity of STING was species-specific, as murine STING (mSTING) did not rescue RV-A16 replication in STING-deficient cells. This species specificity mapped primarily to the cytoplasmic, ligand-binding domain of STING. Mouse-adaptive mutations in the RV-A16 2C protein allowed for robust replication in cells expressing mSTING, suggesting a role for 2C in recruiting STING to RV-A replication organelles. Palmitoylation of STING was not required for RV-A16 replication, nor was the C-terminal tail of STING that mediates IRF3 signaling. Despite co-opting STING to promote its replication, interferon signaling in response to STING agonists remained intact in RV-A16 infected cells. These data demonstrate a surprising requirement for a key host mediator of innate immunity to DNA viruses in the life cycle of a small pathogenic RNA virus.

Indexed as

Carrier ProteinsCommon ColdEnterovirusHeLa CellsHost-Pathogen InteractionsHumansImmunity, InnateInterferon Regulatory Factor-3LipoylationMembrane ProteinsMutationProtein DomainsSignal TransductionSpecies SpecificitySTING ProteinViral Nonstructural Proteins2C protein, viralCarrier ProteinsInterferon Regulatory Factor-3IRF3 protein, humanMembrane ProteinsSTING1 protein, humanSting1 protein, mouseSTING ProteinViral Nonstructural ProteinscGAShost rangeinnate immunityphosphatidylinositol 4-phosphatereplication organelle

Identifiers

PMID33060297
PMCPMC7959528
OpenAlexW3093220899

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.